
July 2026 Research Spotlight: Five Advances Reshaping Type 1 Diabetes Care
From transplant breakthroughs to digital tools and caregiver insights, recent research is expanding treatment options and revealing what helps young people manage their condition better.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Islet-kidney transplantation offers a less invasive option for patients with Type 1 diabetes and kidney failure who cannot undergo traditional pancreas transplants, with over 60% achieving insulin independence in an early North American study.
- Understanding how numbers relate to diabetes management—dosing, carb counting, blood sugar targets—can improve outcomes in teenagers, and video games show promise as a teaching tool.
- Family structure and caregiver identity matter significantly for glycemic control in children; children with widowed or father-as-primary caregivers face greater challenges maintaining stable blood sugar.
- Proper insulin injection technique affects skin health; a new study will examine how injection behavior and subcutaneous fat thickness influence skin complications in children.
A New Path for People With Diabetes and Kidney Disease
When Type 1 diabetes and end-stage kidney disease occur together, simultaneous pancreas-kidney (SPK) transplantation has been the gold standard—but many patients are too medically fragile for surgery. A North American transplant center recently reported results from an alternative: simultaneous islet-kidney (SIK) transplantation, which combines kidney transplant surgery with a less invasive infusion of insulin-producing islet cells.
Between July 2022 and April 2025, 13 patients with Type 1 diabetes and kidney failure underwent SIK after being rejected for SPK, mostly because of blood vessel disease. All 13 patients and their kidney grafts survived follow-up ranging from 4 to 33 months. Kidney function remained stable, and six months after the last islet infusion, 12 of the 13 patients showed detectable C-peptide—a sign that transplanted islet cells were working.
Eight patients (61.5%) achieved insulin independence. Among those still needing insulin, 90% kept their hemoglobin A1c below 7% and reduced insulin needs by 75%. The procedure caused three cases of bleeding after infusion but no severe hypoglycemic episodes. These results suggest SIK is a durable option for patients ineligible for traditional pancreas transplants, offering real metabolic benefit even when insulin independence isn't achieved.
Understanding Numbers: Why Diabetes Numeracy Matters for Teens
Numeracy—the ability to understand and use numbers in daily life—plays an underappreciated role in diabetes management. Low numeracy has been linked to poor outcomes in adults with diabetes, but the teenage experience has been little studied. A recent pilot project explored whether a video game intervention could help adolescents build diabetes-related numeracy skills.
Researchers created a video game designed around diabetes math—concepts like carbohydrate counting, insulin-to-carb ratios, and blood sugar targets. Forty-two adolescents ages 13–18 played the game across three sessions. Before and after, researchers measured diabetes numeracy using the Adolescent Diabetes Numeracy Test (aDNT14) and also assessed general numeracy and health literacy.
At baseline, higher diabetes numeracy scores were significantly linked to better A1c levels. While the full results are still being analyzed, this pilot demonstrates that video games may offer a promising, engaging way to build the numerical reasoning skills that help teens manage their insulin, food, and targets more effectively.
Family Matters: How Caregiver Identity Shapes Blood Sugar Control
A cross-sectional study of 206 children with Type 1 diabetes in Northwest Ethiopia identified striking links between family structure and glycemic control. Overall, 75.7% of children had poor glycemic control, but the rates varied dramatically based on who was managing their care.
Children whose primary caregiver was widowed were 11 times more likely to have poor glycemic control than children with married caregivers. Similarly, children whose father was the primary caregiver were 8 times more likely to have poor control than those whose mother was primary. These findings underscore the role of caregiver stress, capacity, and possibly knowledge in shaping daily diabetes management outcomes.
The results highlight that effective Type 1 diabetes care in children depends not only on individual adherence but on the stability and resources of the family system. Support programs may need to account for caregiver circumstances and offer targeted help to families facing particular challenges.
Injection Technique and Skin Health: A Study in Progress
Insulin injection is a lifelong necessity for people with Type 1 diabetes, yet the link between how injections are done and skin complications has rarely been studied in children. A new observational study, enrolling 199 children with Type 1 diabetes from July 2026 through June 2027, will examine how caregiver injection behavior and subcutaneous fat thickness affect skin problems like lipohypertrophy (thickened tissue at injection sites).
The study will use questionnaires to capture injection practices and ultrasound imaging to measure fat thickness at eight body sites—abdomen, buttocks, arms, and thighs. By correlating technique with physical findings, researchers aim to clarify which injection habits best protect skin health over time. Results may inform guidance for families and clinicians seeking to reduce long-term injection-related complications.
Evidence label
Origin: YouTube / This Month in Type 1 Diabetes Research (Video report). Evidence: Video report, corroborated with 4 indexed studies. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Cure & AdvancementsCell Replacement Therapy: A New Frontier in Type 1 Diabetes ResearchVideo report, corroborated with 5 indexed studies
- Cure & AdvancementsWhy Beta Cells Die in Type 1 Diabetes While Alpha Cells SurviveNews report, corroborated with 2 indexed studies
- Cure & AdvancementsEarly Trial Shows Some People with Type 1 Diabetes Can Reduce or Stop Insulin—Here's What We KnowNews report, corroborated with 3 indexed studies
- Cure & AdvancementsBeta Cell Therapy: Moving From Lab Promise to Real-World TreatmentVideo report, corroborated with 2 indexed studies
- Cure & AdvancementsUnderstanding the Eleodon Trial: What Early Results ShowVideo report — unverified, pending corroboration
- Cure & AdvancementsIslet Cell Therapies Advance: What You Need to KnowNews report, corroborated with 3 indexed studies